Emerald Mutual Fund Advisers Trust United Therapeutics Corp Transaction History
Emerald Mutual Fund Advisers Trust
- $1.45 Billion
- Q4 2024
A detailed history of Emerald Mutual Fund Advisers Trust transactions in United Therapeutics Corp stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 2,702 shares of UTHR stock, worth $832,945. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,702
Previous 311
768.81%
Holding current value
$832,945
Previous $111,000
758.56%
% of portfolio
0.07%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
40.2MCall Options Held
123KPut Options Held
104K-
Black Rock Inc. New York, NY5.47MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.37 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$851 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$678 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$644 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...